WO2022030622A1 - Method for producing compound - Google Patents
Method for producing compound Download PDFInfo
- Publication number
- WO2022030622A1 WO2022030622A1 PCT/JP2021/029343 JP2021029343W WO2022030622A1 WO 2022030622 A1 WO2022030622 A1 WO 2022030622A1 JP 2021029343 W JP2021029343 W JP 2021029343W WO 2022030622 A1 WO2022030622 A1 WO 2022030622A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- group
- compound represented
- general formula
- formula
- production method
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 77
- 150000001875 compounds Chemical class 0.000 title claims abstract description 74
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims abstract description 75
- QMMFVYPAHWMCMS-UHFFFAOYSA-N Dimethyl sulfide Chemical compound CSC QMMFVYPAHWMCMS-UHFFFAOYSA-N 0.000 claims abstract description 45
- 125000005843 halogen group Chemical group 0.000 claims abstract description 20
- 150000007529 inorganic bases Chemical class 0.000 claims abstract description 19
- 125000005278 alkyl sulfonyloxy group Chemical group 0.000 claims abstract description 6
- 125000005279 aryl sulfonyloxy group Chemical group 0.000 claims abstract description 6
- 125000005280 halo alkyl sulfonyloxy group Chemical group 0.000 claims abstract description 6
- 238000006243 chemical reaction Methods 0.000 claims description 75
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 19
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims description 19
- 229910052794 bromium Inorganic materials 0.000 claims description 19
- 238000010438 heat treatment Methods 0.000 claims description 17
- 239000002904 solvent Substances 0.000 claims description 15
- 125000004765 (C1-C4) haloalkyl group Chemical group 0.000 claims description 8
- NSPMIYGKQJPBQR-UHFFFAOYSA-N 4H-1,2,4-triazole Chemical compound C=1N=CNN=1 NSPMIYGKQJPBQR-UHFFFAOYSA-N 0.000 claims description 8
- 125000004767 (C1-C4) haloalkoxy group Chemical group 0.000 claims description 7
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims description 7
- 239000004202 carbamide Substances 0.000 claims description 7
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims description 4
- SPSPIUSUWPLVKD-UHFFFAOYSA-N 2,3-dibutyl-6-methylphenol Chemical compound CCCCC1=CC=C(C)C(O)=C1CCCC SPSPIUSUWPLVKD-UHFFFAOYSA-N 0.000 claims description 4
- IBVAQQYNSHJXBV-UHFFFAOYSA-N adipic acid dihydrazide Chemical compound NNC(=O)CCCCC(=O)NN IBVAQQYNSHJXBV-UHFFFAOYSA-N 0.000 claims description 4
- 235000010354 butylated hydroxytoluene Nutrition 0.000 claims description 4
- 150000007980 azole derivatives Chemical class 0.000 abstract description 23
- 238000000034 method Methods 0.000 abstract description 12
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 63
- -1 triazole-1-yl Chemical group 0.000 description 30
- 238000007792 addition Methods 0.000 description 22
- 239000007788 liquid Substances 0.000 description 20
- 238000003786 synthesis reaction Methods 0.000 description 19
- 230000015572 biosynthetic process Effects 0.000 description 17
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 17
- SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical compound CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 description 16
- 239000000203 mixture Substances 0.000 description 15
- CXOFVDLJLONNDW-UHFFFAOYSA-N Phenytoin Chemical class N1C(=O)NC(=O)C1(C=1C=CC=CC=1)C1=CC=CC=C1 CXOFVDLJLONNDW-UHFFFAOYSA-N 0.000 description 14
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Substances [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 14
- 239000010410 layer Substances 0.000 description 13
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical class CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 12
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
- 239000000543 intermediate Substances 0.000 description 11
- 239000000243 solution Substances 0.000 description 11
- 238000010992 reflux Methods 0.000 description 10
- 239000012043 crude product Substances 0.000 description 9
- KEPJZBFFLDRKSF-UHFFFAOYSA-M trimethylsulfoxonium bromide Chemical compound [Br-].C[S+](C)(C)=O KEPJZBFFLDRKSF-UHFFFAOYSA-M 0.000 description 9
- 238000011002 quantification Methods 0.000 description 8
- 238000003756 stirring Methods 0.000 description 8
- 238000002441 X-ray diffraction Methods 0.000 description 7
- 229910000027 potassium carbonate Inorganic materials 0.000 description 7
- 239000003153 chemical reaction reagent Substances 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 238000004817 gas chromatography Methods 0.000 description 6
- 238000004128 high performance liquid chromatography Methods 0.000 description 6
- 239000003960 organic solvent Substances 0.000 description 6
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 5
- OKJPEAGHQZHRQV-UHFFFAOYSA-N Triiodomethane Natural products IC(I)I OKJPEAGHQZHRQV-UHFFFAOYSA-N 0.000 description 5
- 239000002253 acid Substances 0.000 description 5
- 125000004432 carbon atom Chemical group C* 0.000 description 5
- 238000001035 drying Methods 0.000 description 5
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 5
- 239000007787 solid Substances 0.000 description 5
- BDTJIVUVQRVLLJ-UHFFFAOYSA-N 1-[2-chloro-4-(4-chlorophenoxy)phenyl]ethanone Chemical compound C1=C(Cl)C(C(=O)C)=CC=C1OC1=CC=C(Cl)C=C1 BDTJIVUVQRVLLJ-UHFFFAOYSA-N 0.000 description 4
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 4
- 0 CC1(*)C=CC(Oc2ccc(C(C(O*)=O)O)c(*)c2)=CC=C1 Chemical compound CC1(*)C=CC(Oc2ccc(C(C(O*)=O)O)c(*)c2)=CC=C1 0.000 description 4
- 238000009835 boiling Methods 0.000 description 4
- VAYGXNSJCAHWJZ-UHFFFAOYSA-N dimethyl sulfate Chemical compound COS(=O)(=O)OC VAYGXNSJCAHWJZ-UHFFFAOYSA-N 0.000 description 4
- 238000005886 esterification reaction Methods 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 4
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- 125000000217 alkyl group Chemical group 0.000 description 3
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 3
- 239000000706 filtrate Substances 0.000 description 3
- 229910052740 iodine Inorganic materials 0.000 description 3
- 239000011630 iodine Substances 0.000 description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 3
- YLZOPXRUQYQQID-UHFFFAOYSA-N 3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)-1-[4-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]piperazin-1-yl]propan-1-one Chemical compound N1N=NC=2CN(CCC=21)CCC(=O)N1CCN(CC1)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F YLZOPXRUQYQQID-UHFFFAOYSA-N 0.000 description 2
- RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical class S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 description 2
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 2
- 125000003545 alkoxy group Chemical group 0.000 description 2
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 230000032050 esterification Effects 0.000 description 2
- 230000020169 heat generation Effects 0.000 description 2
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 2
- 239000012044 organic layer Substances 0.000 description 2
- 229910000160 potassium phosphate Inorganic materials 0.000 description 2
- 235000011009 potassium phosphates Nutrition 0.000 description 2
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical class O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 2
- PEUPUKDBCPLDIH-UHFFFAOYSA-N 1,2,4-triazole Chemical group C1=NC=N[N]1 PEUPUKDBCPLDIH-UHFFFAOYSA-N 0.000 description 1
- 125000006218 1-ethylbutyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])[H] 0.000 description 1
- VZSRBBMJRBPUNF-UHFFFAOYSA-N 2-(2,3-dihydro-1H-inden-2-ylamino)-N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]pyrimidine-5-carboxamide Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C(=O)NCCC(N1CC2=C(CC1)NN=N2)=O VZSRBBMJRBPUNF-UHFFFAOYSA-N 0.000 description 1
- 125000001340 2-chloroethyl group Chemical group [H]C([H])(Cl)C([H])([H])* 0.000 description 1
- 125000006176 2-ethylbutyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(C([H])([H])*)C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000004493 2-methylbut-1-yl group Chemical group CC(C*)CC 0.000 description 1
- 125000005916 2-methylpentyl group Chemical group 0.000 description 1
- 125000005917 3-methylpentyl group Chemical group 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- RJUFJBKOKNCXHH-UHFFFAOYSA-N Methyl propionate Chemical compound CCC(=O)OC RJUFJBKOKNCXHH-UHFFFAOYSA-N 0.000 description 1
- MKYBYDHXWVHEJW-UHFFFAOYSA-N N-[1-oxo-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propan-2-yl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(C(C)NC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 MKYBYDHXWVHEJW-UHFFFAOYSA-N 0.000 description 1
- NIPNSKYNPDTRPC-UHFFFAOYSA-N N-[2-oxo-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 NIPNSKYNPDTRPC-UHFFFAOYSA-N 0.000 description 1
- AFCARXCZXQIEQB-UHFFFAOYSA-N N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CCNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 AFCARXCZXQIEQB-UHFFFAOYSA-N 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- 125000001246 bromo group Chemical group Br* 0.000 description 1
- 125000005997 bromomethyl group Chemical group 0.000 description 1
- 125000004106 butoxy group Chemical group [*]OC([H])([H])C([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 1
- FJDQFPXHSGXQBY-UHFFFAOYSA-L caesium carbonate Chemical compound [Cs+].[Cs+].[O-]C([O-])=O FJDQFPXHSGXQBY-UHFFFAOYSA-L 0.000 description 1
- 229910000024 caesium carbonate Inorganic materials 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 125000001309 chloro group Chemical group Cl* 0.000 description 1
- 125000004775 chlorodifluoromethyl group Chemical group FC(F)(Cl)* 0.000 description 1
- 125000004218 chloromethyl group Chemical group [H]C([H])(Cl)* 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 125000001153 fluoro group Chemical group F* 0.000 description 1
- 229910052732 germanium Inorganic materials 0.000 description 1
- GNPVGFCGXDBREM-UHFFFAOYSA-N germanium atom Chemical compound [Ge] GNPVGFCGXDBREM-UHFFFAOYSA-N 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 125000002510 isobutoxy group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])O* 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 125000004491 isohexyl group Chemical group C(CCC(C)C)* 0.000 description 1
- 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000003253 isopropoxy group Chemical group [H]C([H])([H])C([H])(O*)C([H])([H])[H] 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 125000000468 ketone group Chemical group 0.000 description 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
- HAQHJYUYNARRMK-UHFFFAOYSA-N methyl 2-[2-chloro-4-(4-chlorophenoxy)phenyl]-2-oxoacetate Chemical compound ClC1=C(C=CC(=C1)OC1=CC=C(C=C1)Cl)C(C(=O)OC)=O HAQHJYUYNARRMK-UHFFFAOYSA-N 0.000 description 1
- 229940017219 methyl propionate Drugs 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 125000001971 neopentyl group Chemical group [H]C([*])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 150000002924 oxiranes Chemical class 0.000 description 1
- 125000003538 pentan-3-yl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- VBCFDVLVYCYDFZ-UHFFFAOYSA-N potassium;1h-1,2,4-triazole Chemical compound [K].C=1N=CNN=1 VBCFDVLVYCYDFZ-UHFFFAOYSA-N 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000000634 powder X-ray diffraction Methods 0.000 description 1
- 238000001144 powder X-ray diffraction data Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 125000002572 propoxy group Chemical group [*]OC([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 125000003548 sec-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 239000012312 sodium hydride Substances 0.000 description 1
- 229910000104 sodium hydride Inorganic materials 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 125000001973 tert-pentyl group Chemical group [H]C([H])([H])C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 1
- 125000000725 trifluoropropyl group Chemical group [H]C([H])(*)C([H])([H])C(F)(F)F 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
- C07D303/02—Compounds containing oxirane rings
- C07D303/48—Compounds containing oxirane rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
- C07C45/63—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by introduction of halogen; by substitution of halogen atoms by other halogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C67/00—Preparation of carboxylic acid esters
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C67/00—Preparation of carboxylic acid esters
- C07C67/27—Preparation of carboxylic acid esters from ortho-esters
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C67/00—Preparation of carboxylic acid esters
- C07C67/39—Preparation of carboxylic acid esters by oxidation of groups which are precursors for the acid moiety of the ester
- C07C67/42—Preparation of carboxylic acid esters by oxidation of groups which are precursors for the acid moiety of the ester by oxidation of secondary alcohols or ketones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D301/00—Preparation of oxiranes
- C07D301/02—Synthesis of the oxirane ring
Definitions
- the present invention relates to a method for producing a compound.
- Patent Document 1 discloses a method for producing methyl 2- (2-chloro-4- (4-chlorophenoxy) phenyl) -2-oxoacetic acid, which is an intermediate of an azole derivative.
- the present invention has been made in view of the above problems, and one aspect of the present invention is to realize a method capable of producing an intermediate of an azole derivative at a lower cost than an existing production method. do.
- the production method is a production method for a compound represented by the general formula (IV).
- R 1 is a C1-C6 - alkyl group
- X 1 is a halogen group, a C1- C4 -haloalkyl group or a C1- C4 -haloalkoxy group
- X 2 is a halogen group, a C1- C4 -haloalkyl group or a C1- C4 -haloalkoxy group
- n is 1, 2 or 3
- inorganic bases At least one of dimethyl sulfide and dimethyl sulfoxide, and
- Methyl-LG where LG is a nucleophilically replaceable desorbing group, a halogen group, an alkoxysulfonyloxy group, an aryloxysulfonyloxy).
- the production method comprising the step of converting the compound represented by the general formula (II) into the compound represented by the general formula (IV) using the above: [In formula (II), R 1 , X 1 , X 2 , and n are the same as R 1 , X 1 , X 2 , and n in formula (IV)].
- the intermediate of the azole derivative can be produced at a lower cost than the existing production method.
- the X-ray diffraction pattern of the triazole-1-yl body (A) is shown. intensity indicates the X-ray diffraction intensity, and Angle indicates the diffraction angle (2 ⁇ ).
- the X-ray diffraction pattern of the triazole-4-yl body (B) is shown. intensity indicates the X-ray diffraction intensity, and Angle indicates the diffraction angle (2 ⁇ ).
- R 1 is a C1-C6 - alkyl group
- X 1 is a halogen group, a C1- C4 -haloalkyl group or a C1- C4 -haloalkoxy group
- X 2 is a halogen group, a C1- C4 -haloalkyl group or a C1- C4 -haloalkoxy group
- n is 1, 2 or 3].
- the C1 - C6 - alkyl group is a linear or branched alkyl group having 1 to 6 carbon atoms, and is, for example, a methyl group, an ethyl group, a 1-methylethyl group, or a 1,1-dimethyl group.
- Ethyl group propyl group, 1-methylpropyl group, 2-methylpropyl group, 1,1-dimethylpropyl group, 2,2-dimethylpropyl group, 1-ethylpropyl group, butyl group, 1-methylbutyl group, 2- Methylbutyl group, 3-methylbutyl group, 3,3-dimethylbutyl group, 2,2-dimethylbutyl group, 1,1-dimethylbutyl group, 1-ethylbutyl group, 2-ethylbutyl group, pentyl group, 1-methylpentyl group , 2-Methylpentyl group, 3-methylpentyl group or 4-methylpentyl group.
- halogen group examples include a chlorine group, a bromine group, an iodine group or a fluorine group.
- the C1- C4 - haloalkyl group one or two or more halogen atoms are substituted at substitutable positions of the C1- C4 - alkyl group, and when the number of substituted halogen groups is two or more, the halogen is used.
- the groups may be the same or different.
- the C1- C4 - alkyl group is a linear or branched-chain alkyl group having 1 to 4 carbon atoms.
- the C1- C4 - alkyl group is a linear or branched alkyl group having 1 to 4 carbon atoms, and examples thereof include a methyl group, an ethyl group, a propyl group and a butyl group.
- the halogen group is as described above.
- Examples of the C1- C4 - haloalkyl group include a chloromethyl group, a 2-chloroethyl group, a 2,3-dichloropropyl group, a bromomethyl group, a chlorodifluoromethyl group, a trifluoromethyl group, and 3,3,3-. Examples include a trifluoropropyl group.
- the C1- C4 - haloalkoxy group one or two or more halogen atoms are substituted at substitutable positions of the C1- C4 -alkoxy group, and when the number of substituted halogen groups is two or more, the halogen atom is substituted.
- the halogen groups may be the same or different.
- the C1- C4 - alkoxy group is a linear or branched-chain alkoxy group having 1 to 4 carbon atoms.
- the C1- C4 - alkoxy group is a linear or branched alkoxy group having 1 to 4 carbon atoms, and is, for example, a methoxy group, an ethoxy group, a propoxy group, an isopropoxy group, or a 1-methylpropoxy group. , 2-Methylpropoxy group, butoxy group, 1,1-dimethylethoxy group and the like.
- the production method 1 of this embodiment is a step of converting a compound represented by the general formula (II) (hereinafter referred to as “ketoester derivative (II)”) into an oxirane derivative (IV) according to the following scheme 1. (Referred to as "step 1").
- step 1 a compound represented by the general formula (II)
- step 1 a compound represented by the general formula (II)
- step 1 a compound represented by the general formula (II)
- step 1 a compound represented by the general formula (II)
- step 1 a compound represented by the general formula (II)
- step 1 a compound represented by the general formula (II)
- step 1 a compound represented by the general formula (II)
- step 1 a compound represented by the general formula (II)
- step 1 a compound represented by the general formula (II)
- step 1 a compound represented by the general formula (II)
- step 1 a compound represented by the general formula (II)
- step 1 a
- Step 1 In the manufacturing method 1 of this embodiment, the step 1 is In the coexistence of inorganic bases (A) At least one of dimethyl sulfide and dimethyl sulfoxide, and (b) Methyl-LG (where LG is a nucleophilically replaceable desorbing group, a halogen group, an alkoxysulfonyloxy group, an aryloxysulfonyloxy). Group, alkylsulfonyloxy group, haloalkylsulfonyloxy group, and arylsulfonyloxy group) Is a step of converting the ketoester derivative (II) into the oxylan derivative (IV) using the above. [In formula (II), R 1 , X 1 , X 2 , and n are identical to R 1 , X 1 , X 2 , and n in formula (IV)].
- step 1 oxylanation is performed while preparing a sulfonium salt in the reaction system using at least one of dimethyl sulfide and dimethyl sulfoxide and methyl-LG. That is, the preparation of the sulfonium salt and the oxyranization reaction are carried out at the same time.
- the inorganic base is added from the viewpoint of advancing the reaction of step 1.
- Examples of the inorganic base used in step 1 include sodium hydride, cesium carbonate, potassium phosphate, potassium carbonate and the like, and potassium carbonate is preferable.
- LG is a leaving group selected from a nucleophilically replaceable leaving group, for example, a halogen group, an alkoxysulfonyloxy group, an aryloxysulfonyloxy group, an alkylsulfonyloxy group, a haloalkylsulfonyloxy group, and an arylsulfonyloxy group. It shows a group, preferably an alkoxysulfonyloxy group.
- the amount of the inorganic base coexisting in the reaction system in step 1 is 1.0 to 10.0 equivalents (eq.) With respect to 1 equivalent (eq.) Of the ketoester derivative (II) from the viewpoint of advancing the reaction of step 1. ) Is preferable.
- the amount of the above-mentioned “(a) at least one of dimethyl sulfide and dimethyl sulfoxide” (referred to as “required amount of reaction") added to the reaction system in step 1 is the ketoester derivative (II) 1 from the viewpoint of carrying out the reaction in just proportion. It is preferably 1.0 to 10.0 equivalents (eq.) With respect to the equivalent (eq.).
- the amount of the "(b) methyl-LG" added to the reaction system in step 1 (referred to as “required amount of reaction") is 1 equivalent (eq.) Of the ketoester derivative (II) from the viewpoint of carrying out the reaction in just proportion. On the other hand, it is preferably 1.0 to 10.0 equivalents (eq.).
- Step 1 proceeds in an organic solvent.
- a solvent in which the reaction of step 1 proceeds is appropriately selected, and examples thereof include dichloroethane and the like.
- the reaction of step 1 can be carried out, for example, while heating, refluxing and stirring in an oil bath.
- the oil bath temperature may be, for example, 85 to 100 ° C. so that the internal temperature is 80 to 90 ° C.
- step 1 it is preferable to add the reaction required amounts of the above (a) and (b) in divided portions.
- the divided addition in step 1 means that the required reaction amounts of (a) and (b) are added in one or more divided portions.
- a person skilled in the art can appropriately set an appropriate timing and number of additions from the second time onward in consideration of reaction conditions and the like. For example, the second divided addition may be performed before the activity of the reagent added the first time is lost.
- the reaction of (a) and (b) required for the reaction of step 1 is compared with the case where the (a) and (b) are added all at once without the divided addition. It has the effect of reducing the amount of reagents used. It is considered that this is because the reaction is efficiently carried out by the divided addition of (a) and (b) as compared with the case of adding (a) and (b) all at once.
- the addition amount for each addition is not particularly limited.
- the amount of the divided addition can be appropriately adjusted according to the number of times of the divided addition. Further, each divided addition amount (for example, the divided addition amount of the first and second divided additions when the required reaction amount is divided into two portions) may be the same or different.
- the above (a) may be at least one of dimethyl sulfide and dimethyl sulfoxide, but both dimethyl sulfide and dimethyl sulfoxide are preferable.
- the addition of dimethyl sulfide and dimethyl sulfoxide in combination has the effect of not only reducing the amount of reagent used but also improving the yield, as compared with the case where only dimethyl sulfoxide is added. ..
- the production method 1 of this embodiment instead of TMSOB, at least one of dimethyl sulfide and dimethyl sulfoxide, which are relatively easily available, and methyl-LG are used for oxylanation, so that it is not necessary to separately prepare TMSOB.
- the manufacturing method 1 of this embodiment the construction cost of the plant required for manufacturing the TMSOB, the labor cost at the time of manufacturing, the utility cost, etc. are not required, and the practitioner of the manufacturing method 1 of the present embodiment manufactures the TMSOB. It is possible to enjoy manufacturing merits such as shortening of the batch cycle time required for. Further, since the practitioner of the production method 1 of this embodiment handles DMSO under basic conditions, it is possible to enjoy the merit of high safety in production.
- the oxylane derivative (IV) produced by the production method 1 of this embodiment is one of the intermediates of the compound represented by the general formula (I) described later (hereinafter referred to as “azole derivative (I)”).
- the oxylan derivative (IV) can be produced at low cost without using expensive TMSOB, iodine, and iodomethane, so that the azole derivative (I) can be produced at low cost.
- R 1 , X 1 , X 2 , and n are the same as R 1 , X 1 , X 2 , and n in the general formula (IV)].
- the production method 1 of this embodiment may include the production method of the ketoester derivative (II) of this embodiment (hereinafter referred to as “production method 2”) before the step 1.
- the production method 2 of this embodiment is a step of converting a compound represented by the general formula (III) (hereinafter referred to as “methyl ketone derivative (III)”) into a ketoester derivative (II) according to the following scheme 2. (Hereinafter referred to as "step 2") is included.
- R 1 , X 1 , X 2 , and n in the following scheme 2 correspond to R 1 , X 1 , X 2 , and n in the general formula (IV).
- Step 2 bromine is allowed to act on the methyl ketone derivative (III) while heating the reaction system in a solvent containing dimethyl sulfoxide, and then R1 - OH (where R1 is referred to as R1). It is the same as R 1 in the general formula (IV)) to produce a ketoester derivative (II).
- R1 in the general formula (IV)
- X 1 , X 2 , and n are the same as X 1 , X 2 , and n in formula (IV)].
- step 2 the synthesis of ketocarboxylic acid using bromine and dimethyl sulfoxide and the esterification using R1 - OH are continuously carried out.
- the ketoester derivative (II) can be produced at low cost and the yield is high as compared with the case where iodine is used as in Patent Document 1.
- R1 - OH is used as the esterification reagent used in the esterification reaction, the ketoester derivative (II) can be produced at a lower cost as compared with the case where iodomethane is used as in Patent Document 1.
- the amount of dimethyl sulfoxide added to the reaction system in step 2 is 2.0 to 10.0 equivalents (eq.) With respect to 1 equivalent (eq.) Of the methylketone derivative (III) from the viewpoint of carrying out the reaction in just proportion. Is preferable.
- the amount of bromine added to the reaction system in step 2 is 0.5 to 3.0 equivalents (eq.) With respect to 1 equivalent (eq.) Of the methylketone derivative (III) from the viewpoint of carrying out the reaction in just proportion. It is preferable to have.
- the reaction temperature of the ketocarboxylic acid synthesis reaction in step 2 is preferably 60 to 85 ° C, more preferably 70 ° C, from the viewpoint of preferably carrying out the reaction.
- the synthetic reaction of ketocarboxylic acid in step 2 can be carried out while stirring and heating so that the internal temperature becomes the above temperature in an oil bath.
- the esterification reaction in step 2 can be carried out, for example, while heating and refluxing in an oil bath.
- the oil bath temperature may be 60 to 80 ° C. so that the internal temperature is preferably 55 to 65 ° C., more preferably 65 ° C.
- Step 2 proceeds in an organic solvent.
- a solvent in which the reaction of step 2 proceeds is appropriately selected, and examples thereof include dichloroethane and the like.
- step 2 the reaction system to which bromine is added is heated in a solvent containing dimethyl sulfoxide, and then the methyl ketone derivative (III) is added to the methyl ketone derivative (III). Can be reacted with bromine and then with R1-OH (where R 1 is the same as R 1 in the general formula (IV)) to produce the ketoester derivative (II). good.
- the heating temperature of the reaction system before the addition of the methyl ketone derivative (III) is preferably an internal temperature of 60 to 75 ° C., 65. More preferably, it is ° C.
- the reaction temperature of the reaction system after the addition of the methyl ketone derivative (III) is preferably 65 to 80 ° C, more preferably 70 ° C.
- the step 2 is preferably carried out in the coexistence of at least one compound selected from the group consisting of urea, adipic acid dihydrazide and dibutylhydroxytoluene. It is more preferable to carry out in coexistence.
- white deposits are generated in the reaction vessel by using bromine. Although this white deposit is not contained in the final product of step 2, it causes clogging of the reaction vessel, so it is necessary to remove the white deposit in the reaction vessel each time.
- by carrying out the reaction of step 2 in the coexistence of the compound it is possible to suppress the generation of white deposits adhering to the inside of the reaction vessel in step 2.
- the practitioner can enjoy the merit that the production efficiency is improved because the treatment for removing the white deposits in the reaction vessel becomes unnecessary. Since the effect of suppressing the generation of white deposits is high, the compound coexisting in the reaction system in step 2 is preferably urea.
- the amount of at least one compound selected from the group consisting of urea, adipic acid dihydrazide and dibutylhydroxytoluene coexisting in the reaction system in step 2 is the amount of the methyl ketone derivative (III) 1 from the viewpoint of suppressing the generation of white deposits. It is preferably 0.1 to 2.0 equivalents (eq.) With respect to the equivalent (eq.).
- the method for producing the azole derivative (I) of this embodiment (hereinafter referred to as "production method 3") will be described.
- the production method 3 of this embodiment includes the above-mentioned production method of the oxylan derivative (IV) of the present embodiment in order to produce the oxylan derivative (IV) which is an intermediate of the azole derivative (I), and is obtained by the production method.
- a step of converting the obtained oxylan derivative (IV) into an azole derivative (I) according to the following scheme 3 (hereinafter referred to as “step 3”) is included.
- step 3 the oxylan derivative (IV) can be produced at low cost, so that the azole derivative (I) can be produced at low cost.
- R 1 , X 1 , X 2 , and n in the following scheme 3 correspond to R 1 , X 1 , X 2 , and n in the general formula (IV).
- step 3 the oxylan derivative (IV) produced by the production method 1 is used as an azole derivative (I) using 1,2,4-triazole in the presence of an inorganic base. Convert to.
- step 3 1,2,4-triazole and an inorganic base are used, and a salt of 1,2,4-triazole and the inorganic base (for example, when potassium carbonate is used as the inorganic base) in the reaction system. , 1,2,4-Triazole potassium salt) is azoled.
- 1,2,4-Triazole potassium salt is azoled.
- the inorganic base used in step 3 is as illustrated in the description of step 1.
- the inorganic base used in step 3 may be the same as or different from the inorganic base used in step 1.
- the amount of the inorganic base coexisting in the reaction system in step 3 is 0.1 to 3.0 equivalents (eq.) With respect to 1 equivalent (eq.) Of the oxylane derivative (IV) from the viewpoint of advancing the reaction in step 3. ) Is preferable.
- the amount of 1,2,4-triazole added to the reaction system in step 3 is 1.0 to 1 equivalent (eq.) Of the oxylan derivative (IV) from the viewpoint of carrying out the reaction of step 3 in just proportion. It is preferably 3.0 equivalents (eq.).
- Step 3 proceeds in an organic solvent.
- a solvent in which the reaction of step 3 proceeds is appropriately selected, and examples thereof include N, N-dimethylformamide, N, N-dimethylacetamide and the like.
- the reaction of step 3 can be carried out, for example, with stirring at room temperature or while heating and stirring in an oil bath.
- the reaction temperature at this time is, for example, an internal temperature of 40 to 120 ° C.
- the method for converting the oxylan derivative (IV) to the azole derivative (I) is not limited to the above-mentioned method, and a known method (for example, the method disclosed in Patent Document 1) can also be used. be. Therefore, the production method 3 according to another aspect of the present invention includes the above-mentioned method for producing the oxylan derivative (IV) of the present embodiment, and the oxylan derivative (IV) obtained by the production method is used as a known method ( For example, it may be a method of converting to an azole derivative (I) according to the method disclosed in Patent Document 1).
- the production method is a method for producing a compound represented by the general formula (IV), in which (a) at least one of dimethyl sulfide and dimethylsulfoxide, and (b) in the presence of an inorganic base.
- Methyl-LG where LG is a nucleophilically replaceable desorbing group, a halogen group, an alkoxysulfonyloxy group, an aryloxysulfonyloxy group, an alkylsulfonyloxy group, a haloalkylsulfonyloxy group, and an arylsulfonyloxy group.
- (Selected from the group) is used to convert the compound represented by the general formula (II) into the compound represented by the general formula (IV). With such a configuration, the oxylan derivative (IV) can be produced without using costly TMSOB.
- the reaction required amounts of the above (a) and the above (b) are divided and added. It is preferable to do so. Since the reaction is efficiently carried out by the divided addition of (a) and (b), the amount of the reagent used in (a) and (b) can be reduced.
- the above (a) is preferably both dimethyl sulfide and dimethyl sulfoxide.
- the addition of dimethyl sulfide has the effect of reducing the amount of reagent used in (a).
- the production method according to the fourth aspect further comprises, in any one of the first to third aspects, the step 2 of converting the compound represented by the general formula (III) into the compound represented by the general formula (II).
- step 2 bromine is allowed to act on the compound represented by the general formula (III) while heating the reaction system in a solvent containing dimethyl sulfoxide, and then R 1 ⁇ OH (where R 1 is represented by the formula (where R 1 is)).
- R 1 ⁇ OH where R 1 is represented by the formula (where R 1 is)
- It may be configured to produce the compound represented by the general formula (II) by allowing the action (which is the same as R 1 in IV). With such a configuration, the ketoester derivative (II) can be produced without using costly iodine or iodomethane.
- the reaction system to which bromine is added is heated in a solvent containing dimethyl sulfoxide and then generally used.
- the compound represented by the formula (III) is added to cause bromine to act on the compound represented by the general formula (III), and then R 1 -OH (where R 1 is R in the formula (IV)). It is preferable to carry out the same reaction as 1 ) to produce the compound represented by the general formula (II).
- the step 2 for converting to the compound represented by the general formula (II) is selected from the group consisting of urea, adipic acid dihydrazide and dibutylhydroxytoluene. It is preferable to carry out in the coexistence of at least one kind. With such a configuration, it is possible to suppress the generation of white deposits adhering to the inside of the reaction vessel in step 2.
- the production method according to this aspect 7 is a method for producing a compound represented by the general formula (I), and is a method for producing a compound represented by the general formula (IV) according to any one of the present aspects 1 to 6.
- the compound represented by the general formula (IV) obtained by the production method is represented by the general formula (I) using 1,2,4-triazole in the presence of an inorganic base. It is a configuration including a step 3 for converting into a compound to be made. With such a configuration, the production cost of the intermediate of the azole derivative (I) can be reduced, so that the production cost of the azole derivative (I) can be reduced.
- dimethyl sulfoxide 468 of 2'-chloro-4'-(4-chlorophenoxy) acetophenone 283.11 g (1.00 mol) A .77 g (6.00 mol) solution was added with a dropping funnel.
- 39.07 g (0.50 mol) of dimethyl sulfoxide and 6 mL of dichloroethane were added.
- the low boiling material was distilled off, 500 mL of toluene and 500 mL of methanol were added, and the mixture was heated under reflux.
- Synthesis Example 2-3 the generation of white deposits adhering to the inside of the reaction vessel could be suppressed by 95% or more as compared with Synthesis Example 2-1 and Synthesis Example 2-2.
- the present invention can be used as a method for producing an intermediate for synthesizing an azole derivative useful as a pesticide.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
X1は、ハロゲン基、C1-C4-ハロアルキル基又はC1-C4-ハロアルコキシ基であり;
X2は、ハロゲン基、C1-C4-ハロアルキル基又はC1-C4-ハロアルコキシ基であり;
nは、1、2又は3である]
無機塩基の共存下にて、
(a)ジメチルスルフィド及びジメチルスルホキシドの少なくとも一方、並びに
(b)メチル-LG(ここで、LGは求核的に置換可能な脱離基であり、ハロゲン基、アルコキシスルホニルオキシ基、アリールオキシスルホニルオキシ基、アルキルスルホニルオキシ基、ハロアルキルスルホニルオキシ基、及びアリールスルホニルオキシ基から選ばれる)
を用いて、一般式(II)で表される化合物を前記一般式(IV)で表される化合物に変換する工程を含むことを特徴とする、製造方法:
X 1 is a halogen group, a C1- C4 -haloalkyl group or a C1- C4 -haloalkoxy group;
X 2 is a halogen group, a C1- C4 -haloalkyl group or a C1- C4 -haloalkoxy group;
n is 1, 2 or 3]
In the coexistence of inorganic bases
(A) At least one of dimethyl sulfide and dimethyl sulfoxide, and (b) Methyl-LG (where LG is a nucleophilically replaceable desorbing group, a halogen group, an alkoxysulfonyloxy group, an aryloxysulfonyloxy). Group, alkylsulfonyloxy group, haloalkylsulfonyloxy group, and arylsulfonyloxy group)
The production method comprising the step of converting the compound represented by the general formula (II) into the compound represented by the general formula (IV) using the above:
本発明の一態様に係る一般式(IV)で表される化合物(以下、「オキシラン誘導体(IV)」と称する)の製造方法(以下「製造方法1」と称する)について説明する:
X1は、ハロゲン基、C1-C4-ハロアルキル基又はC1-C4-ハロアルコキシ基であり;
X2は、ハロゲン基、C1-C4-ハロアルキル基又はC1-C4-ハロアルコキシ基であり;
nは、1、2又は3である]。 [1. Method for producing a compound represented by the general formula (IV)]
A method for producing a compound represented by the general formula (IV) according to one aspect of the present invention (hereinafter referred to as "oxylan derivative (IV)") (hereinafter referred to as "production method 1") will be described:
X 1 is a halogen group, a C1- C4 -haloalkyl group or a C1- C4 -haloalkoxy group;
X 2 is a halogen group, a C1- C4 -haloalkyl group or a C1- C4 -haloalkoxy group;
n is 1, 2 or 3].
本態様の製造方法1における、工程1は、
無機塩基の共存下にて、
(a)ジメチルスルフィド及びジメチルスルホキシドの少なくとも一方、並びに
(b)メチル-LG(ここで、LGは求核的に置換可能な脱離基であり、ハロゲン基、アルコキシスルホニルオキシ基、アリールオキシスルホニルオキシ基、アルキルスルホニルオキシ基、ハロアルキルスルホニルオキシ基、及びアリールスルホニルオキシ基から選ばれる)
を用いて、ケトエステル誘導体(II)をオキシラン誘導体(IV)に変換する工程である。
In the manufacturing method 1 of this embodiment, the step 1 is
In the coexistence of inorganic bases
(A) At least one of dimethyl sulfide and dimethyl sulfoxide, and (b) Methyl-LG (where LG is a nucleophilically replaceable desorbing group, a halogen group, an alkoxysulfonyloxy group, an aryloxysulfonyloxy). Group, alkylsulfonyloxy group, haloalkylsulfonyloxy group, and arylsulfonyloxy group)
Is a step of converting the ketoester derivative (II) into the oxylan derivative (IV) using the above.
本態様の製造方法1は、工程1の前に、本態様のケトエステル誘導体(II)の製造方法(以下、「製造方法2」と称する)を含んでもよい。 [2. Method for producing ketoester derivative (II)]
The production method 1 of this embodiment may include the production method of the ketoester derivative (II) of this embodiment (hereinafter referred to as “production method 2”) before the step 1.
本態様の製造方法2において、工程2では、ジメチルスルホキシドを含む溶媒中、反応系を加熱しながらメチルケトン誘導体(III)に臭素を作用させ、次いで、R1-OH(ここで、R1は、前記一般式(IV)中のR1と同一である)を作用させて、ケトエステル誘導体(II)を生成する。
In the production method 2 of this embodiment, in step 2, bromine is allowed to act on the methyl ketone derivative (III) while heating the reaction system in a solvent containing dimethyl sulfoxide, and then R1 - OH (where R1 is referred to as R1). It is the same as R 1 in the general formula (IV)) to produce a ketoester derivative (II).
本態様のアゾール誘導体(I)の製造方法(以下「製造方法3」と称する)について説明する。本態様の製造方法3は、アゾール誘導体(I)の中間体であるオキシラン誘導体(IV)を製造するために、前述した本態様のオキシラン誘導体(IV)の製造方法を含み、当該製造方法によって得られたオキシラン誘導体(IV)を、以下のスキーム3に従って、アゾール誘導体(I)に変換する工程(以下、「工程3」と称する)を含む。かかる構成により、オキシラン誘導体(IV)を安価に製造することができるため、アゾール誘導体(I)を安価に製造することができる。 [3. Method for Producing Azole Derivative (I)]
The method for producing the azole derivative (I) of this embodiment (hereinafter referred to as "production method 3") will be described. The production method 3 of this embodiment includes the above-mentioned production method of the oxylan derivative (IV) of the present embodiment in order to produce the oxylan derivative (IV) which is an intermediate of the azole derivative (I), and is obtained by the production method. A step of converting the obtained oxylan derivative (IV) into an azole derivative (I) according to the following scheme 3 (hereinafter referred to as “step 3”) is included. With such a configuration, the oxylan derivative (IV) can be produced at low cost, so that the azole derivative (I) can be produced at low cost.
本態様1に係る製造方法は、一般式(IV)で表される化合物の製造方法であって、無機塩基の共存下にて、(a)ジメチルスルフィド及びジメチルスルホキシドの少なくとも一方、並びに(b)メチル-LG(ここで、LGは求核的に置換可能な脱離基であり、ハロゲン基、アルコキシスルホニルオキシ基、アリールオキシスルホニルオキシ基、アルキルスルホニルオキシ基、ハロアルキルスルホニルオキシ基、及びアリールスルホニルオキシ基から選ばれる)を用いて、一般式(II)で表される化合物を前記一般式(IV)で表される化合物に変換する工程1を含む構成である。かかる構成により、コストのかかるTMSOBを用いずに、オキシラン誘導体(IV)を製造することができる。 〔summary〕
The production method according to the first aspect is a method for producing a compound represented by the general formula (IV), in which (a) at least one of dimethyl sulfide and dimethylsulfoxide, and (b) in the presence of an inorganic base. Methyl-LG (where LG is a nucleophilically replaceable desorbing group, a halogen group, an alkoxysulfonyloxy group, an aryloxysulfonyloxy group, an alkylsulfonyloxy group, a haloalkylsulfonyloxy group, and an arylsulfonyloxy group. (Selected from the group) is used to convert the compound represented by the general formula (II) into the compound represented by the general formula (IV). With such a configuration, the oxylan derivative (IV) can be produced without using costly TMSOB.
2-(2-クロロ-4-(4-クロロフェノキシ)フェニル)-2-オキシランカルボン酸メチル
(合成例1-1)
2-(2-クロロ-4-(4-クロロフェノキシ)フェニル)-2-オキソ酢酸メチル0.98g(3.0mmol)、ジクロロエタン4.5mLをフラスコに加えた後、炭酸カリウム2.24g(16.2mmol)、硫酸ジメチル1.54mL(16.2mmol)、及びジメチルスルホキシド0.58mL(8.1mmol)を加えて95℃のオイルバスで加熱還流撹拌した。反応開始から2時間後、水を加え、ジクロロエタンで2回抽出し、これを1回水洗した。無水硫酸ナトリウムで乾燥後、溶媒を留去し、黄色液体粗製物1.06gを得た。 <Synthesis example 1>
Methyl 2- (2-chloro-4- (4-chlorophenoxy) phenyl) -2-oxylancarboxylate (Synthesis Example 1-1)
Add 0.98 g (3.0 mmol) of 2- (2-chloro-4- (4-chlorophenoxy) phenyl) -2-oxoacetic acid methyl 0.98 g (3.0 mmol) and 4.5 mL of dichloroethane to the flask, and then add 2.24 g (16) of potassium carbonate. .2 mmol), 1.54 mL (16.2 mmol) of dimethyl sulfate, and 0.58 mL (8.1 mmol) of dimethyl sulfoxide were added, and the mixture was heated under reflux in an oil bath at 95 ° C. and stirred. Two hours after the start of the reaction, water was added, the mixture was extracted twice with dichloroethane, and this was washed once with water. After drying over anhydrous sodium sulfate, the solvent was distilled off to obtain 1.06 g of a crude yellow liquid.
粗2-(2-クロロ-4-(4-クロロフェノキシ)フェニル)-2-オキソ酢酸メチル12.90g(純度76%、30mmol)、炭酸カリウム14.95g(108mmol)、及びジクロロエタン60mLをフラスコに加えた後、ジメチルスルホキシド3.84mL(54mmol)、及び硫酸ジメチル10.26mL(108mmol)を分割して加えた。反応は95℃のオイルバスを用いて加熱還流下で行った。反応開始から7.5時間後、水を加えて分液し、水層をジクロロエタンで1回再抽出した後、有機層を合わせて2回水洗した。無水硫酸ナトリウムで乾燥後、溶媒を留去し、橙色液体粗製物13.07gを得た。 (Synthesis Example 1-2)
Crude 2- (2-chloro-4- (4-chlorophenoxy) phenyl) -2-oxomethyl acetate 12.90 g (purity 76%, 30 mmol), potassium carbonate 14.95 g (108 mmol), and 60 mL dichloroethane in a flask. After the addition, 3.84 mL (54 mmol) of dimethyl sulfoxide and 10.26 mL (108 mmol) of dimethyl sulfate were added in portions. The reaction was carried out under heating and reflux using an oil bath at 95 ° C. After 7.5 hours from the start of the reaction, water was added to separate the liquids, the aqueous layer was re-extracted once with dichloroethane, and then the organic layers were combined and washed twice. After drying over anhydrous sodium sulfate, the solvent was distilled off to obtain 13.07 g of a crude orange liquid.
粗2-(2-クロロ-4-(4-クロロフェノキシ)フェニル)-2-オキソ酢酸メチル17.18g(純度76%、40mmol)、炭酸カリウム13.27g(96mmol)、ジメチルスルフィド1.8mL(24mmol)、及びジクロロエタン60mLをフラスコに加えた後、ジメチルスルホキシド3.4mL(48mmol)、及び硫酸ジメチル7.1mL(96mmol)を分割して加えた。反応は95℃のオイルバスを用いて加熱還流下で行った。反応開始から5時間後、水を加えて分液し、有機層を2回水洗した。無水硫酸ナトリウムで乾燥後、溶媒を留去し、橙色液体粗製物17.50gを得た。 (Synthesis Example 1-3)
Crude 2- (2-chloro-4- (4-chlorophenoxy) phenyl) -2-oxomethyl acetate 17.18 g (purity 76%, 40 mmol), potassium carbonate 13.27 g (96 mmol), dimethyl sulfide 1.8 mL ( 24 mmol) and 60 mL of dichloroethane were added to the flask, followed by addition of 3.4 mL (48 mmol) of dimethyl sulfoxide and 7.1 mL (96 mmol) of dimethyl sulfate in portions. The reaction was carried out under heating and reflux using an oil bath at 95 ° C. After 5 hours from the start of the reaction, water was added to separate the liquids, and the organic layer was washed twice. After drying over anhydrous sodium sulfate, the solvent was distilled off to obtain 17.50 g of a crude orange liquid.
2-(2-クロロ-4-(4-クロロフェノキシ)フェニル)-2-オキソ酢酸メチル0.98g(3.0mmol)、リン酸カリウム3.82g(18.0mmol)、及びジクロロエタン6.0mLをフラスコに加えた後、硫酸ジメチル0.85mL(9.0mmol)、及びジメチルスルホキシド0.32mL(4.5mmol)を分割して加えた。反応は95℃のオイルバスで加熱還流下で行った。反応開始から7時間後、水を加え、ジクロロエタンで2回抽出し、これを1回水洗した。無水硫酸ナトリウムで乾燥後、溶媒を留去し、黄色液体粗製物1.16gを得た。 (Synthesis Example 1-4)
2- (2-Chloro-4- (4-chlorophenoxy) phenyl) -2-oxomethyl acetate 0.98 g (3.0 mmol), potassium phosphate 3.82 g (18.0 mmol), and dichloroethane 6.0 mL. After addition to the flask, 0.85 mL (9.0 mmol) of dimethyl sulfate and 0.32 mL (4.5 mmol) of dimethyl sulfoxide were added in portions. The reaction was carried out in an oil bath at 95 ° C. under heating and reflux. After 7 hours from the start of the reaction, water was added, the mixture was extracted twice with dichloroethane, and this was washed once with water. After drying over anhydrous sodium sulfate, the solvent was distilled off to obtain 1.16 g of a crude yellow liquid.
2-(2-クロロ-4-(4-クロロフェノキシ)フェニル)-2-オキソ酢酸メチルの合成
(合成例2-1)
2’-クロロ-4’-(4-クロロフェノキシ)アセトフェノン28.11g(0.10mol)、ジメチルスルホキシド50mL、及びジクロロエタン45mLをフラスコに加えて溶解し氷浴で冷却した後、臭素19.32g(0.12mol)を滴下ロートで加え、ジクロロエタン5mLで洗いこみ、内温が70℃になるようにオイルバスで加熱撹拌した。1時間後、低沸物を留去し、トルエン50mL、及びメタノール50mLを加えて加熱還流した。1時間後、トルエン50mLを加えて溶液の下層を分離し、下層をトルエンで1回再抽出した。上層と再抽出トルエンを合わせて飽和重層水で1回洗浄し、1回水洗し、飽和食塩水で1回洗浄した。無水硫酸ナトリウムで乾燥後、溶媒を留去し、橙色液体粗製物30.83gを得た。 <Synthesis example 2>
Synthesis of 2- (2-chloro-4- (4-chlorophenoxy) phenyl) -2-oxomethyl acetate (Synthesis Example 2-1)
Add 28.11 g (0.10 mol) of 2'-chloro-4'-(4-chlorophenoxy) acetophenone, 50 mL of dimethyl sulfoxide, and 45 mL of dichloroethane to a flask, dissolve, cool in an ice bath, and then 19.32 g of bromine (. 0.12 mol) was added with a dropping funnel, washed with 5 mL of dichloroethane, and heated and stirred in an oil bath so that the internal temperature became 70 ° C. After 1 hour, the low boiling material was distilled off, 50 mL of toluene and 50 mL of methanol were added, and the mixture was heated under reflux. After 1 hour, 50 mL of toluene was added to separate the lower layer of the solution and the lower layer was re-extracted once with toluene. The upper layer and the re-extracted toluene were combined and washed once with saturated brine, washed once with water, and washed once with saturated brine. After drying over anhydrous sodium sulfate, the solvent was distilled off to obtain 30.83 g of a crude orange liquid.
ジクロロエタン100mLをフラスコに加えた後、臭素38.36g(0.24mol)を滴下ロートで加えて撹拌した。反応容器を水浴で冷却した後、ジメチルスルホキシド28.4mLを滴下ロートで加えた。オイルバスで内温が70℃になるように加熱した後、2’-クロロ-4’-(4-クロロフェノキシ)アセトフェノン56.23g(0.20mol)のジメチルスルホキシド85.2mL溶液を滴下ロートで加えた。滴下終了から1時間後、ジメチルスルホキシド7.1mLを追加した。更に1時間後、低沸物を留去し、トルエン100mL、及びメタノール100mLを加えて加熱還流した。2時間後、トルエン100mLを加えて溶液の下層を分離し、下層をトルエンで1回再抽出した。上層と再抽出トルエンを合わせて飽和重層水で1回洗浄し、2回水洗した。溶媒を留去し、橙色液体粗製物59.29gを得た。 (Synthesis Example 2-2)
After adding 100 mL of dichloroethane to the flask, 38.36 g (0.24 mol) of bromine was added with a dropping funnel and stirred. After cooling the reaction vessel in a water bath, 28.4 mL of dimethyl sulfoxide was added with a dropping funnel. After heating in an oil bath to an internal temperature of 70 ° C., a solution of 56.23 g (0.20 mol) of 2'-chloro-4'-(4-chlorophenoxy) acetophenone in dimethyl sulfoxide 85.2 mL is added with a dropping funnel. added. One hour after the completion of the dropping, 7.1 mL of dimethyl sulfoxide was added. After another 1 hour, the low boiling material was distilled off, 100 mL of toluene and 100 mL of methanol were added, and the mixture was heated under reflux. After 2 hours, 100 mL of toluene was added to separate the lower layer of the solution and the lower layer was re-extracted once with toluene. The upper layer and the re-extracted toluene were combined and washed once with saturated layered water and washed twice. The solvent was distilled off to obtain 59.29 g of a crude orange liquid.
尿素18.01g(0.30mol)、及びジクロロエタン468mLをフラスコに加えた後、臭素191.80g(1.20mol)を滴下ロートで加えて撹拌した。反応容器を水浴で冷却した後、ジメチルスルホキシド156.26g(2.00mol)及びジクロロエタン25mLの混合溶液を滴下ロートで加えた。オイルバスで内温が70℃になるまで内温を見ながら段階的に加熱した後、2’-クロロ-4’-(4-クロロフェノキシ)アセトフェノン283.11g(1.00mol)のジメチルスルホキシド468.77g(6.00mol)溶液を滴下ロートで加えた。滴下終了から1時間後、ジメチルスルホキシド39.07g(0.50mol)及びジクロロエタン6mLを追加した。更に1時間後、低沸物を留去し、トルエン500mL及びメタノール500mLを加えて加熱還流した。3時間後、トルエン500mLを追加して溶液の下層を分離し、下層をトルエンで1回再抽出した。上層と再抽出トルエンを合わせて水で1回、5%重層水で1回、水で1回洗浄した。目的物のトルエン溶液1671.78gを橙色液体として得た。 (Synthesis Example 2-3)
After adding 18.01 g (0.30 mol) of urea and 468 mL of dichloroethane to the flask, 191.80 g (1.20 mol) of bromine was added with a dropping funnel and stirred. After cooling the reaction vessel in a water bath, a mixed solution of 156.26 g (2.00 mol) of dimethyl sulfoxide and 25 mL of dichloroethane was added with a dropping funnel. After gradually heating in an oil bath while observing the internal temperature until the internal temperature reaches 70 ° C, dimethyl sulfoxide 468 of 2'-chloro-4'-(4-chlorophenoxy) acetophenone 283.11 g (1.00 mol) A .77 g (6.00 mol) solution was added with a dropping funnel. One hour after the completion of the dropping, 39.07 g (0.50 mol) of dimethyl sulfoxide and 6 mL of dichloroethane were added. After another 1 hour, the low boiling material was distilled off, 500 mL of toluene and 500 mL of methanol were added, and the mixture was heated under reflux. After 3 hours, 500 mL of toluene was added to separate the lower layer of the solution and the lower layer was re-extracted once with toluene. The upper layer and the re-extracted toluene were combined and washed once with water, once with 5% layered water, and once with water. 1671.78 g of the desired toluene solution was obtained as an orange liquid.
ジクロロエタン500mL、及び臭素191.79g(1.20mol)をフラスコに加えた後、内温が65℃になるまでオイルバスで加熱撹拌した後、尿素18.02g(0.30mol)のジメチルスルホキシド156.28g(2.00mol)溶液を滴下ロートで加えた。その後、2’-クロロ-4’-(4-クロロフェノキシ)アセトフェノン283.68g(純度99.1%,1.00mol)のジメチルスルホキシド351.59g(4.50mol)溶液を滴下ロートで加えた。滴下終了から1時間後、ジメチルスルホキシド39.13g(0.50mol)を追加した。更に2時間後、低沸物を留去し、トルエン500mL及びメタノール500mLを加えて加熱還流した。7時間後、溶液の下層を分離し、下層をトルエンで1回再抽出した。上層と再抽出トルエンを合わせて3回水洗した。目的物のトルエン溶液1261.67gを橙色液体として得た。 (Synthesis Example 2-4)
After adding 500 mL of dichloroethane and 191.79 g (1.20 mol) of bromine to the flask, heating and stirring in an oil bath until the internal temperature reaches 65 ° C., dimethyl sulfoxide 156 of 18.02 g (0.30 mol) of urea. A 28 g (2.00 mol) solution was added with a dropping funnel. Then, a solution of 283.68 g (purity 99.1%, 1.00 mol) of dimethyl sulfoxide 351.59 g (4.50 mol) of 2'-chloro-4'-(4-chlorophenoxy) acetophenone was added with a dropping funnel. One hour after the completion of the dropping, 39.13 g (0.50 mol) of dimethyl sulfoxide was added. After another 2 hours, the low boiling material was distilled off, 500 mL of toluene and 500 mL of methanol were added, and the mixture was heated under reflux. After 7 hours, the lower layer of the solution was separated and the lower layer was re-extracted once with toluene. The upper layer and the re-extracted toluene were combined and washed with water three times. 261.67 g of a toluene solution of interest was obtained as an orange liquid.
2-(2-クロロ-4-(4-クロロフェノキシ)フェニル)-2-ヒドロキシ-3-(1H-1,2,4-トリアゾール-1-イル)プロピオン酸メチルの合成
粗2-(2-クロロ-4-(4-クロロフェノキシ)フェニル)-2-オキシランカルボン酸メチル152.35g(純度74%、0.33mol)、及びN,N-ジメチルアセトアミド154.12gをフラスコに加えた後、1,2,4-トリアゾール34.64g(0.50mol)、及び炭酸カリウム23.09g(0.17mol)を加え、50℃のオイルバスで加熱撹拌した。0.75時間後、内温を60℃に昇温した。5時間後、室温まで冷却し、反応液363.71gの内、111.95g(0.10mol相当)を500mLの円筒型セパラブルフラスコに移し、トルエン50mL及び水40mLを加えた後、標記化合物の種晶30mgを加えた。30分後、水160mLを滴下して30分間室温で撹拌した後、6℃のシクロヘキサンバスを用いて30分かけてゆっくり冷却し、3時間撹拌を続けた。その後、粗液を吸引ろ過し、水50mL及びトルエン25mLを用いて洗浄した。ろ取物を真空検体乾燥機を用いて減圧乾燥し目的物の白色固体粗製物を39.09g得た。 <Synthesis example 3>
2- (2-Chloro-4- (4-chlorophenoxy) phenyl) -2-hydroxy-3- (1H-1,2,4-triazole-1-yl) Synthesis of methyl propionate Crude 2- (2- (2-) After adding 152.35 g of methyl chloro-4- (4-chlorophenoxy) phenyl) -2-oxylancarboxylate (purity 74%, 0.33 mol) and 154.12 g of N, N-dimethylacetamide to the flask, 1 , 2,4-Triazole 34.64 g (0.50 mol) and potassium carbonate 23.09 g (0.17 mol) were added, and the mixture was heated and stirred in an oil bath at 50 ° C. After 0.75 hours, the internal temperature was raised to 60 ° C. After 5 hours, the mixture was cooled to room temperature, 111.95 g (equivalent to 0.10 mol) of the reaction solution 363.71 g was transferred to a 500 mL cylindrical separable flask, 50 mL of toluene and 40 mL of water were added, and then the title compound was added. 30 mg of seed crystals were added. After 30 minutes, 160 mL of water was added dropwise and the mixture was stirred at room temperature for 30 minutes, then slowly cooled over 30 minutes using a cyclohexane bath at 6 ° C., and stirring was continued for 3 hours. Then, the crude liquid was suction-filtered and washed with 50 mL of water and 25 mL of toluene. The filtrate was dried under reduced pressure using a vacuum sample dryer to obtain 39.09 g of the desired white solid crude product.
Claims (7)
- 一般式(IV)で表される化合物の製造方法であって、
X1は、ハロゲン基、C1-C4-ハロアルキル基又はC1-C4-ハロアルコキシ基であり;
X2は、ハロゲン基、C1-C4-ハロアルキル基又はC1-C4-ハロアルコキシ基であり;
nは、1、2又は3である]
無機塩基の共存下にて、
(a)ジメチルスルフィド及びジメチルスルホキシドの少なくとも一方、並びに
(b)メチル-LG(ここで、LGは求核的に置換可能な脱離基であり、ハロゲン基、アルコキシスルホニルオキシ基、アリールオキシスルホニルオキシ基、アルキルスルホニルオキシ基、ハロアルキルスルホニルオキシ基、及びアリールスルホニルオキシ基から選ばれる)
を用いて、一般式(II)で表される化合物を前記一般式(IV)で表される化合物に変換する工程を含むことを特徴とする、製造方法:
X 1 is a halogen group, a C1- C4 -haloalkyl group or a C1- C4 -haloalkoxy group;
X 2 is a halogen group, a C1- C4 -haloalkyl group or a C1- C4 -haloalkoxy group;
n is 1, 2 or 3]
In the coexistence of inorganic bases
(A) At least one of dimethyl sulfide and dimethyl sulfoxide, and (b) Methyl-LG (where LG is a nucleophilically replaceable desorbing group, a halogen group, an alkoxysulfonyloxy group, an aryloxysulfonyloxy). Group, alkylsulfonyloxy group, haloalkylsulfonyloxy group, and arylsulfonyloxy group)
The production method comprising the step of converting the compound represented by the general formula (II) into the compound represented by the general formula (IV) using the above:
- 前記一般式(IV)で表される化合物に変換する工程では、前記(a)及び前記(b)の反応必要量を分割して添加することを特徴とする、請求項1に記載の製造方法。 The production method according to claim 1, wherein in the step of converting to the compound represented by the general formula (IV), the required reaction amounts of the above (a) and (b) are added in divided portions. ..
- 前記(a)は、ジメチルスルフィド及びジメチルスルホキシドの両方である、請求項1又は2に記載の製造方法。 The production method according to claim 1 or 2, wherein (a) is both dimethyl sulfide and dimethyl sulfoxide.
- 一般式(III)で表される化合物を前記一般式(II)で表される化合物に変換する工程をさらに含み、
当該工程では、ジメチルスルホキシドを含む溶媒中、反応系を加熱しながら一般式(III)で表される化合物に臭素を作用させ、次いで、R1-OH(ここで、R1は、式(IV)中のR1と同一である)を作用させて、前記一般式(II)で表される化合物を生成することを特徴とする、請求項1から3のいずれか1項に記載の製造方法:
In this step, bromine is allowed to act on the compound represented by the general formula (III) while heating the reaction system in a solvent containing dimethyl sulfoxide, and then R1 - OH (where R1 is represented by the formula (IV)). The production method according to any one of claims 1 to 3, wherein the compound represented by the general formula (II) is produced by the action of (same as R1 in). :
- 前記一般式(II)で表される化合物に変換する工程では、ジメチルスルホキシドを含む溶媒中、臭素を添加した反応系を加熱した後に、一般式(III)で表される化合物を添加して一般式(III)で表される化合物に臭素を作用させ、次いで、R1-OH(ここで、R1は、式(IV)中のR1と同一である)を作用させて、前記一般式(II)で表される化合物を生成することを特徴とする、請求項4に記載の製造方法。 In the step of converting to the compound represented by the general formula (II), the reaction system to which bromine is added is heated in a solvent containing dimethyl sulfoxide, and then the compound represented by the general formula (III) is added and generally used. The compound represented by the formula (III) is allowed to act on bromine, and then R1 - OH (where R1 is the same as R1 in the formula (IV)) is allowed to act on the compound represented by the above general formula. The production method according to claim 4, wherein the compound represented by (II) is produced.
- 前記一般式(II)で表される化合物に変換する工程は、尿素、アジピン酸ジヒドラジド及びジブチルヒドロキシトルエンからなる群から選択される少なくとも1種の共存下にて行うことを特徴とする、請求項4又は5に記載の製造方法。 The step of converting to the compound represented by the general formula (II) is characterized in that it is carried out in the coexistence of at least one selected from the group consisting of urea, adipic acid dihydrazide and dibutylhydroxytoluene. The manufacturing method according to 4 or 5.
- 一般式(I)で表される化合物の製造方法であって、
請求項1から6のいずれか1項に記載の一般式(IV)で表される化合物の製造方法を含み、
当該製造方法によって得られた前記一般式(IV)で表される化合物を、無機塩基の共存下にて、1,2,4-トリアゾールを用いて、前記一般式(I)で表される化合物に変換する工程を含むことを特徴とする製造方法:
A method for producing a compound represented by the general formula (IV) according to any one of claims 1 to 6 is included.
The compound represented by the general formula (IV) obtained by the production method, using 1,2,4-triazole in the presence of an inorganic base, is represented by the general formula (I). A manufacturing method comprising a step of converting to:
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2022541750A JP7427096B2 (en) | 2020-08-06 | 2021-08-06 | Method for producing compounds |
US18/040,365 US20230271929A1 (en) | 2020-08-06 | 2021-08-06 | Method for producing compound |
EP21853755.3A EP4194445A4 (en) | 2020-08-06 | 2021-08-06 | Method for producing compound |
CN202180060304.5A CN116171273B (en) | 2020-08-06 | 2021-08-06 | Process for producing compound |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2020-134138 | 2020-08-06 | ||
JP2020134138 | 2020-08-06 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2022030622A1 true WO2022030622A1 (en) | 2022-02-10 |
Family
ID=80118171
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2021/029343 WO2022030622A1 (en) | 2020-08-06 | 2021-08-06 | Method for producing compound |
Country Status (5)
Country | Link |
---|---|
US (1) | US20230271929A1 (en) |
EP (1) | EP4194445A4 (en) |
JP (1) | JP7427096B2 (en) |
CN (1) | CN116171273B (en) |
WO (1) | WO2022030622A1 (en) |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS59206375A (en) * | 1983-04-29 | 1984-11-22 | バイエル・アクチエンゲゼルシヤフト | Manufacture of oxiranes |
CN102491959A (en) * | 2011-12-19 | 2012-06-13 | 江苏澄扬作物科技有限公司 | Preparation method of oxirane derivative |
JP2012530109A (en) * | 2009-06-18 | 2012-11-29 | ビーエーエスエフ ソシエタス・ヨーロピア | Antibacterial 1,2,4-triazolyl derivative |
JP2012530110A (en) * | 2009-06-18 | 2012-11-29 | ビーエーエスエフ ソシエタス・ヨーロピア | Antibacterial 1,2,4-triazolyl derivative |
CN103059004A (en) * | 2012-12-21 | 2013-04-24 | 泰州职业技术学院 | Method of preparing 1-[Alpha-(2, 4-difluorophenyl)-2, 3-glycidyl]-1H-1, 2, 4-triazole |
WO2016005211A1 (en) * | 2014-07-08 | 2016-01-14 | Basf Se | Process for the preparation of substituted oxiranes and triazoles |
WO2019093522A1 (en) | 2017-11-13 | 2019-05-16 | 株式会社クレハ | Azole derivative, intermediate compound, method for producing azole derivative, agent for agricultural and horticultural use, and material protection agent for industrial use |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2013069615A1 (en) * | 2011-11-11 | 2013-05-16 | 株式会社クレハ | Method for producing 4-benzyl-1-methyl-6-oxabicyclo[3,2,0]heptane derivative |
WO2014057844A1 (en) * | 2012-10-11 | 2014-04-17 | 株式会社クレハ | Method for producing cycloalkanol derivative, and method for producing azole derivative |
-
2021
- 2021-08-06 JP JP2022541750A patent/JP7427096B2/en active Active
- 2021-08-06 US US18/040,365 patent/US20230271929A1/en active Pending
- 2021-08-06 WO PCT/JP2021/029343 patent/WO2022030622A1/en active Application Filing
- 2021-08-06 CN CN202180060304.5A patent/CN116171273B/en active Active
- 2021-08-06 EP EP21853755.3A patent/EP4194445A4/en active Pending
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS59206375A (en) * | 1983-04-29 | 1984-11-22 | バイエル・アクチエンゲゼルシヤフト | Manufacture of oxiranes |
JP2012530109A (en) * | 2009-06-18 | 2012-11-29 | ビーエーエスエフ ソシエタス・ヨーロピア | Antibacterial 1,2,4-triazolyl derivative |
JP2012530110A (en) * | 2009-06-18 | 2012-11-29 | ビーエーエスエフ ソシエタス・ヨーロピア | Antibacterial 1,2,4-triazolyl derivative |
CN102491959A (en) * | 2011-12-19 | 2012-06-13 | 江苏澄扬作物科技有限公司 | Preparation method of oxirane derivative |
CN103059004A (en) * | 2012-12-21 | 2013-04-24 | 泰州职业技术学院 | Method of preparing 1-[Alpha-(2, 4-difluorophenyl)-2, 3-glycidyl]-1H-1, 2, 4-triazole |
WO2016005211A1 (en) * | 2014-07-08 | 2016-01-14 | Basf Se | Process for the preparation of substituted oxiranes and triazoles |
WO2019093522A1 (en) | 2017-11-13 | 2019-05-16 | 株式会社クレハ | Azole derivative, intermediate compound, method for producing azole derivative, agent for agricultural and horticultural use, and material protection agent for industrial use |
Non-Patent Citations (4)
Title |
---|
KAMBALE DIGAMBAR A., THORAT SAGAR S., PRATAPURE MADHUKAR S., GONNADE RAJESH G., KONTHAM RAVINDAR: "Lewis acid catalyzed cascade annulation of alkynols with α-ketoesters: a facile access to γ-spiroketal-γ-lactones", CHEMICAL COMMUNICATIONS, vol. 53, no. 49, 1 January 2017 (2017-01-01), UK , pages 6641 - 6644, XP055796654, ISSN: 1359-7345, DOI: 10.1039/C7CC03668J * |
RAGHUNADH AKULA, MERUVA SURESH, KUMAR NUKA, KUMAR GUDLA, RAO L., SYAM KUMAR U.: "An Efficient and Practical Synthesis of Aryl and Hetaryl α-Keto Esters", SYNTHESIS, vol. 2012, no. 02, 1 January 2012 (2012-01-01), STUTTGART, DE. , pages 283 - 289, XP055907477, ISSN: 0039-7881, DOI: 10.1055/s-0031-1289647 * |
See also references of EP4194445A4 |
SON JUNG-HO, ZHU JIE S., PHUAN PUAY-WAH, CIL ONUR, TEUTHORN ANDREW P., KU COLTON K., LEE SUJIN, VERKMAN ALAN S., KURTH MARK J.: "High-Potency Phenylquinoxalinone Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Activators", JOURNAL OF MEDICINAL CHEMISTRY, vol. 60, no. 6, 23 March 2017 (2017-03-23), US , pages 2401 - 2410, XP055907577, ISSN: 0022-2623, DOI: 10.1021/acs.jmedchem.6b01759 * |
Also Published As
Publication number | Publication date |
---|---|
US20230271929A1 (en) | 2023-08-31 |
JP7427096B2 (en) | 2024-02-02 |
JPWO2022030622A1 (en) | 2022-02-10 |
CN116171273B (en) | 2024-05-14 |
EP4194445A4 (en) | 2024-08-14 |
CN116171273A (en) | 2023-05-26 |
EP4194445A1 (en) | 2023-06-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2010518144A (en) | Process for producing entacapone substantially free of the Z isomer, synthetic intermediates thereof, and novel crystalline forms | |
JP2008239629A (en) | Novel polymorph of venlafaxine hydrochloride and method for preparing it | |
IE41849B1 (en) | Phenylsulphinyl and thio amidine derivatives | |
CN104540800A (en) | Process for the preparation of (2Z,5Z)-5-(3-chloro-4- ((R)-2,3-dihydroxypropoxy)benzylidene)-2-(propylimino)-3-(o-tolyl)thiazolidin-4-one and intermediate used in said process | |
WO2022030622A1 (en) | Method for producing compound | |
JPS6185353A (en) | Manufacture of 4-phenyl-pyrrole derivative | |
JP7065638B2 (en) | Imidazole salt and its manufacturing method | |
DK3250556T3 (en) | PROCEDURES FOR THE PREPARATION OF COMPOUNDS, SUCH AS 3-ARYL BUTANALS THAT CAN BE USED FOR THE SYNTHESIS OF MEDETOMIDINE | |
CN111333558A (en) | Visible light promoted α -selenone compound synthesis method | |
JPH0458472B2 (en) | ||
JP6251197B2 (en) | Process for preparing substituted phenylpropanones | |
WO2012042532A1 (en) | Process for preparing bicalutamide | |
EP3109236B1 (en) | Scalable process for the preparation of sorafenib tosylate ethanol solvate and sorafenib tosylate form iii | |
JP4800532B2 (en) | Method for producing acylated 1,3-dicarbonyl compounds | |
JP7515684B2 (en) | Method for producing azole derivatives | |
JPWO2016043189A1 (en) | Method for producing triphenylbutene derivative | |
JP2013124248A (en) | Manufacturing method for 4,4-difluoro-3,4-dihydroisoquinolines | |
JPH02289563A (en) | Improved process for producing ortho-carboxypyridyl- and ortho-carboxyquinolylimidazolinones | |
JP7183476B2 (en) | Compound manufacturing method | |
JPH03170467A (en) | Benzothiazepine | |
EP3609877B1 (en) | Process for the synthesis of firocoxib | |
JP7198201B2 (en) | Method for producing difluoromethylene compound | |
US4410732A (en) | Phenyl ketone derivatives | |
KR101354175B1 (en) | Method of preparing methyl (e)-2-(3-methoxy)acrylate from 2-(3,3-demethoxy)propanoate | |
CN111909110A (en) | Preparation method of 2, 4-disubstituted thiazole compound |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 21853755 Country of ref document: EP Kind code of ref document: A1 |
|
ENP | Entry into the national phase |
Ref document number: 2022541750 Country of ref document: JP Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 202317005660 Country of ref document: IN |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2021853755 Country of ref document: EP |
|
NENP | Non-entry into the national phase |
Ref country code: DE |